Nom du produit:2-Amino-9-(3-hydroxypropoxy)-1H-purin-6(9H)-one
IUPAC Name:2-amino-9-(3-hydroxypropoxy)-6,9-dihydro-1H-purin-6-one
| Unité d'emballage | Stock disponible | Prix($) | Quantité |
|---|
| Product Overview |
2-Amino-9-(3-hydroxypropoxy)-1H-purin-6(9H)-one is an antiviral medication used to treat infections caused by herpes viruses. It was first synthesized in 1977 by Gertrude Elion and George Hitchings at Burroughs Wellcome (now GlaxoSmithKline). 2-Amino-9-(3-hydroxypropoxy)-1H-purin-6(9H)-one is an acyclic guanine nucleoside analog that selectively inhibits viral DNA polymerase, thereby preventing viral replication. |
| Physical Properties |
2-Amino-9-(3-hydroxypropoxy)-1H-purin-6(9H)-one is soluble in DMSO. |
| Chemical Properties |
2-Amino-9-(3-hydroxypropoxy)-1H-purin-6(9H)-one is a reactive compound, often utilized as a starting material or intermediate in various chemical reactions and synthesis processes. |
| Synthesis and Application |
2-Amino-9-(3-hydroxypropoxy)-1H-purin-6(9H)-one has been extensively studied for its antiviral activity against herpes simplex virus (HSV) types 1 and 2, varicella-zoster virus (VZV), and Epstein-Barr virus (EBV). It has also been investigated for its potential use in the treatment of other viral infections, such as cytomegalovirus (CMV) and human immunodeficiency virus (HIV). |
| Storage and Handling |
Store 2-Amino-9-(3-hydroxypropoxy)-1H-purin-6(9H)-one at -20°C. |
Recherche 
+86 21 5895 0110 
